vs
MERIT MEDICAL SYSTEMS INC（MMSI）与SCANSOURCE, INC.（SCSC）财务数据对比。点击上方公司名可切换其他公司
SCANSOURCE, INC.的季度营收约是MERIT MEDICAL SYSTEMS INC的2.0倍（$766.5M vs $381.9M），MERIT MEDICAL SYSTEMS INC净利率更高（10.7% vs 2.2%，领先8.6%），MERIT MEDICAL SYSTEMS INC同比增速更快（7.5% vs 2.5%），SCANSOURCE, INC.自由现金流更多（$28.9M vs $24.7M），过去两年MERIT MEDICAL SYSTEMS INC的营收复合增速更高（6.3% vs 0.9%）
梅里特医疗系统公司是一家全球性医疗设备企业，设计、生产和销售适用于心脏病学、放射学、肿瘤学、内窥镜及重症监护领域的介入和诊断产品，为全球医院及医疗机构提供微创医疗解决方案，助力提升患者疗效和临床操作效率。
ScanSource是全球领先的专业技术分销商，主营销售点系统、条码扫描设备、网络安全产品、云服务及通信解决方案，面向北美、拉美、欧洲的增值经销商、服务提供商及企业客户，覆盖零售、医疗、工业、公共部门等领域。
MMSI vs SCSC — 直观对比
营收规模更大
SCSC
是对方的2.0倍
$381.9M
营收增速更快
MMSI
高出4.9%
2.5%
净利率更高
MMSI
高出8.6%
2.2%
自由现金流更多
SCSC
多$4.2M
$24.7M
两年增速更快
MMSI
近两年复合增速
0.9%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $381.9M | $766.5M |
| 净利润 | $41.0M | $16.5M |
| 毛利率 | 48.4% | 13.4% |
| 营业利润率 | 11.6% | 2.3% |
| 净利率 | 10.7% | 2.2% |
| 营收同比 | 7.5% | 2.5% |
| 净利润同比 | 36.0% | -3.3% |
| 每股收益（稀释后） | $0.68 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MMSISCSC
| Q1 26 | $381.9M | — | ||
| Q4 25 | $393.9M | $766.5M | ||
| Q3 25 | $384.2M | $739.6M | ||
| Q2 25 | $382.5M | $812.9M | ||
| Q1 25 | $355.4M | $704.8M | ||
| Q4 24 | $355.2M | $747.5M | ||
| Q3 24 | $339.8M | $775.6M | ||
| Q2 24 | $338.0M | $746.1M |
净利润MMSISCSC
| Q1 26 | $41.0M | — | ||
| Q4 25 | $38.0M | $16.5M | ||
| Q3 25 | $27.8M | $19.9M | ||
| Q2 25 | $32.6M | $20.1M | ||
| Q1 25 | $30.1M | $17.4M | ||
| Q4 24 | $27.9M | $17.1M | ||
| Q3 24 | $28.4M | $17.0M | ||
| Q2 24 | $35.7M | $16.1M |
毛利率MMSISCSC
| Q1 26 | 48.4% | — | ||
| Q4 25 | 49.6% | 13.4% | ||
| Q3 25 | 48.5% | 14.5% | ||
| Q2 25 | 48.2% | 12.9% | ||
| Q1 25 | 48.4% | 14.2% | ||
| Q4 24 | 48.7% | 13.6% | ||
| Q3 24 | 46.4% | 13.1% | ||
| Q2 24 | 47.7% | 13.0% |
营业利润率MMSISCSC
| Q1 26 | 11.6% | — | ||
| Q4 25 | 13.8% | 2.3% | ||
| Q3 25 | 11.1% | 3.5% | ||
| Q2 25 | 12.3% | 3.3% | ||
| Q1 25 | 11.5% | 3.2% | ||
| Q4 24 | 10.3% | 2.5% | ||
| Q3 24 | 11.0% | 2.3% | ||
| Q2 24 | 13.6% | 2.9% |
净利率MMSISCSC
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.6% | 2.2% | ||
| Q3 25 | 7.2% | 2.7% | ||
| Q2 25 | 8.5% | 2.5% | ||
| Q1 25 | 8.5% | 2.5% | ||
| Q4 24 | 7.9% | 2.3% | ||
| Q3 24 | 8.4% | 2.2% | ||
| Q2 24 | 10.6% | 2.2% |
每股收益（稀释后）MMSISCSC
| Q1 26 | $0.68 | — | ||
| Q4 25 | $0.64 | $0.75 | ||
| Q3 25 | $0.46 | $0.89 | ||
| Q2 25 | $0.54 | $0.87 | ||
| Q1 25 | $0.49 | $0.74 | ||
| Q4 24 | $0.46 | $0.70 | ||
| Q3 24 | $0.48 | $0.69 | ||
| Q2 24 | $0.61 | $0.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $488.1M | $83.5M |
| 总债务越低越好 | $735.2M | — |
| 股东权益账面价值 | $1.6B | $910.9M |
| 总资产 | $2.7B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资MMSISCSC
| Q1 26 | $488.1M | — | ||
| Q4 25 | $446.4M | $83.5M | ||
| Q3 25 | $392.5M | $124.9M | ||
| Q2 25 | $341.8M | $126.2M | ||
| Q1 25 | $395.5M | $146.3M | ||
| Q4 24 | $376.7M | $110.5M | ||
| Q3 24 | $523.1M | $145.0M | ||
| Q2 24 | $636.7M | $185.5M |
总债务MMSISCSC
| Q1 26 | $735.2M | — | ||
| Q4 25 | $734.0M | — | ||
| Q3 25 | $732.9M | — | ||
| Q2 25 | $731.8M | — | ||
| Q1 25 | $730.7M | — | ||
| Q4 24 | $729.6M | — | ||
| Q3 24 | $750.5M | — | ||
| Q2 24 | $801.3M | — |
股东权益MMSISCSC
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $910.9M | ||
| Q3 25 | $1.5B | $914.0M | ||
| Q2 25 | $1.5B | $906.4M | ||
| Q1 25 | $1.4B | $901.7M | ||
| Q4 24 | $1.4B | $900.7M | ||
| Q3 24 | $1.3B | $920.9M | ||
| Q2 24 | $1.3B | $924.3M |
总资产MMSISCSC
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $1.7B | ||
| Q3 25 | $2.6B | $1.7B | ||
| Q2 25 | $2.6B | $1.8B | ||
| Q1 25 | $2.5B | $1.7B | ||
| Q4 24 | $2.4B | $1.7B | ||
| Q3 24 | $2.4B | $1.8B | ||
| Q2 24 | $2.4B | $1.8B |
负债/权益比MMSISCSC
| Q1 26 | 0.45× | — | ||
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $30.8M |
| 自由现金流经营现金流 - 资本支出 | $24.7M | $28.9M |
| 自由现金流率自由现金流/营收 | 6.5% | 3.8% |
| 资本支出强度资本支出/营收 | 4.2% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 1.87× |
| 过去12个月自由现金流最近4个季度 | $220.8M | — |
8季度趋势，按日历期对齐
经营现金流MMSISCSC
| Q1 26 | — | — | ||
| Q4 25 | $98.5M | $30.8M | ||
| Q3 25 | $75.0M | $23.2M | ||
| Q2 25 | $83.3M | — | ||
| Q1 25 | $40.6M | $66.1M | ||
| Q4 24 | $68.7M | $-6.2M | ||
| Q3 24 | $47.3M | $44.8M | ||
| Q2 24 | $68.5M | — |
自由现金流MMSISCSC
| Q1 26 | $24.7M | — | ||
| Q4 25 | $74.0M | $28.9M | ||
| Q3 25 | $52.5M | $20.8M | ||
| Q2 25 | $69.6M | — | ||
| Q1 25 | $19.5M | $64.6M | ||
| Q4 24 | $65.3M | $-8.2M | ||
| Q3 24 | $38.0M | $42.5M | ||
| Q2 24 | $57.9M | — |
自由现金流率MMSISCSC
| Q1 26 | 6.5% | — | ||
| Q4 25 | 18.8% | 3.8% | ||
| Q3 25 | 13.7% | 2.8% | ||
| Q2 25 | 18.2% | — | ||
| Q1 25 | 5.5% | 9.2% | ||
| Q4 24 | 18.4% | -1.1% | ||
| Q3 24 | 11.2% | 5.5% | ||
| Q2 24 | 17.1% | — |
资本支出强度MMSISCSC
| Q1 26 | 4.2% | — | ||
| Q4 25 | 6.2% | 0.3% | ||
| Q3 25 | 5.8% | 0.3% | ||
| Q2 25 | 3.6% | 0.3% | ||
| Q1 25 | 5.9% | 0.2% | ||
| Q4 24 | 1.0% | 0.3% | ||
| Q3 24 | 2.8% | 0.3% | ||
| Q2 24 | 3.1% | 0.2% |
现金转化率MMSISCSC
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | 1.87× | ||
| Q3 25 | 2.70× | 1.17× | ||
| Q2 25 | 2.56× | — | ||
| Q1 25 | 1.35× | 3.79× | ||
| Q4 24 | 2.46× | -0.36× | ||
| Q3 24 | 1.66× | 2.64× | ||
| Q2 24 | 1.92× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MMSI
暂无分部数据
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
